Table 1.
Overall (n = 54) |
TERT C228T‐positive in NMU (n = 16) |
TERT C228T‐negative in NMU (n = 38) |
|
---|---|---|---|
No. | No. (%) | No. (%) | |
Gender | |||
Male | 39 | 13 (33) | 26 (67) |
Female | 15 | 3 (20) | 12 (80) |
Age, years | |||
Median (range) | 73 (33–87) | 72 (59–86) | 73 (33–87) |
Number of tumors | |||
Single | 28 | 7 (25) | 21 (75) |
2–7 | 25 | 9 (36) | 16 (64) |
≥ 8 | 1 | 0 (0) | 1 (100) |
Tumor diameter | |||
< 3 cm | 46 | 12 (26) | 34 (74) |
≥ 3 cm | 8 | 4 (50) | 4 (50) |
Prior recurrence rate | |||
Primary | 43 | 12 (28) | 31 (72) |
≤ 1 recurrence/year | 6 | 2 (33) | 4 (67) |
> 1 recurrence/year | 5 | 2 (40) | 3 (60) |
Pathological T stage | |||
pTa | 26 | 6 (23) | 20 (77) |
pT1 | 25 | 10 (40) | 15 (60) |
Concurrent CIS | 12 | 4 (33) | 8 (67) |
≥ pT2 | 0 | ||
No malignancy | 0 | ||
Grade | |||
G1 | 0 | ||
G2 | 27 | 8 (30) | 19 (70) |
G3 | 27 | 8 (30) | 19 (70) |